Reuters: Regulatory News: UPDATE 1-FDA approves Sanofi/Regeneron colon cancer drug

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-FDA approves Sanofi/Regeneron colon cancer drug Aug 3rd 2012, 16:17 Fri Aug 3, 2012 12:17pm EDT Aug 3 (Reuters) - The U.S. Food and Drug Administration said on Friday that it had approved Sanofi SA and Regeneron Pharmaceuticals Inc drug Zaltrap for metastatic colorectal cancer patients whose tumors have failed to respond to earlier treatment with chemotherapy. The medicine, to be taken in combination with standard chemotherapy, will compete with Roche Holding AG's Avastin and Bristol-Myers Squibb Co's Erbitux. Industry analysts say they expect Zaltrap to win relatively wide use, but doubt it will overtake sales of those widely used older treatments.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions